Repository logo
 

Longitudinal Outcomes of Dolutegravir-Based Antiretroviral Therapy in a Large Nigerian Programmatic HIV-1 Cohort, 2017-2019.

Accepted version
Peer-reviewed

Repository URI

https://www.repository.cam.ac.uk/handle/1810/407431

Repository DOI

https://doi.org/10.17863/CAM.133573
Thumbnail Image

Files

Primary Accepted version (224.5 KB)

Type

Article

Change log

Authors

Abdullahi, Adam  ORCID logo  https://orcid.org/0000-0001-9703-8264
Kwabena, Asare  ORCID logo  https://orcid.org/0000-0002-5074-2315

Abstract

In a retrospective Nigerian cohort of 33 982 people with HIV-1 initiating or switching to tenofovir, lamivudine, and dolutegravir, virological suppression reached 80%-82% among participants with available viral load data and 63%-65% by intention-to-treat analysis. Suppression was higher among switchers, while age and gender predicted suppression.

Description

Keywords

Dolutegravir, HIV, Nigeria, antiretroviral therapy, treatment outcomes, virological suppression

Journal Title

Open Forum Infect Dis

Conference Name

Journal ISSN

2328-8957
2328-8957

Volume Title

Publisher

Oxford University Press (OUP)

Publisher DOI

https://doi.org/10.1093/ofid/ofag549

Rights and licensing

Attribution 4.0 International
Except where otherwised noted, this item's license is described as Attribution 4.0 International
Sponsorship
Wellcome Trust Senior fellowship (WT108082AIA).

Collections

University of Cambridge Research Outputs (Articles and Conferences)